Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Brilacidin failed to help with the primary objective in the first test with humans sick with the new virus. Is that *failed spectacularly* for you?

Well, we were notified of primary objective failure. It's now over two months out and we have no further data from secondary endpoints or CU. Thus far it has produced nothing of value that we are aware of. That's pretty much what failing spectacularly is in a clinical trial.

Maybe that will change if we get positive news in the update to come shortly. As of now I assume B-COVID is done and we're moving on to other indications.

For my knowledge it did not hurt anyone.

It felt pretty terrible for anyone holding shares. I know I got hurt.